BEIJING, Dec 8 – Novogene, a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte Ltd, a Singapore biotechnology company; and the Genome Institute of Singapore (GIS) announced today that NovogeneAIT Genomics Singapore (NovogeneAIT) will establish a joint whole genome sequencing (WGS) centre at Biopolis, Singapore. The new centre will provide Illumina HiSeq X based whole genome sequencing and bioinformatics analysis of human, plant and animal samples for biomedical and agricultural researchers.
The centre will devote a major portion of its sequencing capability to support public research projects and empower super scale sequencing initiatives in Singapore and the region. In addition, NovogeneAIT will collaborate with GIS to develop new applications of next-generation sequencing, such as WGS solutions for cancer diagnosis and stratified cancer treatment.
“I am very excited and pleased to announce this significant new initiative with the Genome Institute of Singapore. The centre is the first major project for NovogeneAIT and is an important milestone for our company. We look forward to providing high-quality sequencing services in Singapore and to advancing important research initiatives that can benefit humanity,” stated Dr. Ruiqiang Li, CEO of Novogene.
“We are delighted to work with a local biotech company. Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies,” said Prof. Ng Huck Hui, Executive Director of GIS.